禽Ⅰ型副粘病毒各种禽源分离株的免疫原性

分别制备了源于鸡、鹅、鸽、鹌鹑、孔雀、画眉鸟、珍珠鸡的禽型副粘病毒(APMV-1)7个强毒分离毒株和商品弱毒疫苗株克隆30(C30)的灭活油乳剂苗,并用这8种灭活油乳剂苗和C30株的活疫苗分别在鸡、鹌鹑、鹅和鸽进行了免疫及交叉攻毒保护试验。免疫后(PI)分别测定试验禽血清的新城疫病毒(NDV)血凝抑制(HI)抗体的滴度,并于PI 5周用强毒株进行攻毒。结果表明,鸽的HI抗体几何平均滴度(MAT)为9.00~10.0 log2,鸡的为7.13~7.63 log2,鹌鹑的为5.00~5.13 log2,鹅对灭活油乳剂苗的为5.63~6.38 log2、而对C30株活疫苗的仅为3.38log2;除了C30株活疫苗免疫鹅提供的保护率比较低(20%)外,8种油乳剂苗都能对同源或者异源强毒株的攻毒提供比较高的保护率(66.75%~100%)。研究结果表明,经典疫苗株C30与近年来从各种不同禽类分离的致病性APMV-1野毒株之间、不同禽源分离株之间的抗原性,以及各种不同禽源分离株的之间的免疫原性差异均不大。     

H9亚型禽流感病毒流行毒株交叉免疫攻毒保护试验

采用1998-2009年在河北、河南及山东分离的3株禽流感H9亚型流行毒株,分别制备灭活疫苗,免疫SPF鸡,免疫后21 d,采血测定HI抗体,然后用从上述3个地区及北京分离的共5株禽流感H9亚型流行毒株进行攻击,观察不同时期及地点分离的H9亚型流行毒株的交叉免疫攻毒保护效果。结果显示,用不同时期及地点的3个分离毒株所制备出的灭活疫苗免疫鸡后,各免疫组试验鸡H9亚型禽流感的HI抗体效价均明显上升,不同毒株灭活疫苗所诱导产生的HI抗体效价存在着不同程度的差异,用同源毒株作为抗原测定免疫组鸡的血清样品,可获得较高的HI抗体效价。攻毒试验结果证明,对不同时期及地点分离的禽流感H9亚型流行毒株间产生了较好的交叉保护力。用1998年分离的WD98株制备出的灭活疫苗对目前的流行毒株仍具有较好的保护效力。     

Pepper resistance-breaking tobamoviruses: Can they co-exist in single pepper plants?

We previously reported a procedure for identifying pathotypes of the tobamoviruses infecting the L-resistant genotypes of pepper based on the polymerase chain reaction (PCR) (Tenllado et al., 1994). We have now used this method to assess pathotype incidence in virus isolates from field pepper samples representing three successive epidemic episodes in southeastern Spain, and to analyse the interaction of pathotypes during experimental infections in pepper plants. The majority of virus isolates corresponded to the P_1,2 pathotype, and only three out of twenty behaved as P_1,2,3 pathotypes. Interestingly, restriction enzyme analysis of the PCR-amplified products distinguished two restriction subgroups on each P_1,2 and P_1,2,3 pathotype, referred to as restrictopatterns I₁ and I₂ or II₁ and II₂, respectively. Experimental coinoculations of pepper plants with mixtures of two different pathotypes showed coexistence between them when inoculations proceeded simultaneously. However, reciprocal cross-protection was observed between P_1,2 and P_1,2,3 pathotypes when they were successively inoculated, while no cross-protection was observed between P₁ and either P_1,2 or P_1,2,3 pathotypes. The potential of the PCR-based method for detecting heterogeneity within P_1,2 and P_1,2,3 pathotypes, and the possibility of genetically engineered resistance to those viruses by genetic transformation with viral coat protein genes are briefly discussed.     

Cross-protection of a live-attenuated Flavobacterium psychrophilum immersion vaccine against novel Flavobacterium spp. and Chryseobacterium spp. strains

For salmonid producers, a common threat is Flavobacterium psychrophilum. Recent advancements in bacterial coldwater disease (BCWD) management include the development of a live-attenuated immersion vaccine that cross-protects against an array of F. psychrophilum strains. Emerging family Flavobacteriaceae cases associated with clinical disease have been increasing, including pathogenic isolates of Flavobacterium spp. and Chryseobacterium spp. The cross-protective ability of a live-attenuated F. psychrophilum vaccine was determined against three virulent Flavobacteriaceae isolates. Juvenile rainbow trout were vaccinated, developed high F. psychrophilum-specific antibody titres and were challenged with Chryseobacterium spp. isolates (S25 and T28), a Flavobacterium sp. (S21) isolate, a mixed combination of S21:S25:T28, and a standard virulent F. psychrophilum CSF259-93 strain. Results demonstrated strong protection in the CSF259-93 vaccinated group (relative per cent survival (RPS)=94.44%) when compared to the relevant CSF259-93 controls (p < .001). Protection was also observed for vaccinated fish challenged with the S21:S25:T28 mix (RPS = 85.18%; p < .001). However, protection was not observed with the S21, S25 or T28 isolates alone. Analysis of whole-cell lysates revealed differences in protein banding by SDS-PAGE, but conserved antigenic regions by Western blot in S25 and T28. Results demonstrate that this live-attenuated vaccine provided protection against mixed flavobacterial infection and suggest further benefits against flavobacteriosis.     

Cross-protection elicited in channel catfish (Ictalurus punctatus Rafinesque) immunized with a low dose of virulent Edwardsiella ictaluri strains

Cross-protection of channel catfish ( Ictalurus punctatus Rafinesque) immunized with a low dose of virulent Edwardsiella ictaluri and challenged with six E. ictaluri strains was examined in four trials. The relative per cent survival among low-dose immunized and then challenged fish ranged from 27.7% to 100%. Significant protection ( P <0.05), with the exception of strain ATCC-33202, was conferred by immunization with a given E. ictaluri strain challenged either with a homologous or a heterologous strain. Antibody titres of pooled serum collected on day 22 from surviving fish examined by enzyme-linked immunosorbent assay (ELISA) ranged from 1:40 to 1:320, but no differences were apparent among different vaccinated groups. The protein profiles of six E. ictaluri strains examined by Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) showed a relatively homogeneous pattern. Immuno-blots probed with pooled serum from immunized and challenged fish showed a pattern similar to LPS-reaction patterns observed with E. ictaluri in other studies. Since the present studies further corroborate that E. ictaluri is a clonal bacterial species with no apparent antigenic differences, it is possible that immunization with a single E. ictaluri field strain should confer protection against any other strain.     

Evaluation of protection conferred by a vaccination program based on the H120 and CR88 commercial vaccines against a field variant of avian infectious bronchitis virus

Due to serotype variations among different avian infectious bronchitis viruses isolated in Tunisia since 2000, protection of chicks, especially broiler flocks, with Mass H120 vaccine often fails. Therefore, association of CR88 (793B type) with H120 vaccines was used for better response. Challenge experiments were then conducted to evaluate tracheal and renal cross-protection in chickens immunized via nasal and eye drops. Conferred protection was measured by clinical signs and macroscopic lesions observed, based on scores attributed according to their severities. The results showed a low protection conferred by H120 alone, as vaccination did not reduce tracheal and kidney lesions (70% scored as 3) after TN20/00 virus challenge, which also led to 10% mortality. Conversely, the challenge results indicated that the combination of the 2 strains (H120/CR88) allow high protection. Based on the results of the challenge experiments, a vaccination protocol coupling CR88 to H120 was applied for industrial broiler flocks. Clinical observations and serological results confirmed that association of heterologous serotypes (H120 and CR88 vaccines) increased the levels of protection against infectious bronchitis viruses compared with the H120 vaccine given alone.     

1型和2型鸭疫里默氏菌的交叉保护

通过PCR扩增、克隆、序列测定获得29株鸭疫里默氏菌(RA)的16S rRNA和16S-23S rRNA间隔区的核苷酸序列.将16S rRNA和16S-23S rRNA间隔区序列连接后分析发现,1型菌株和大多数2型菌株分别处于不同的分支,而2型菌株中的RAf11、RAf3和RAf104不处在2型菌株的分支中,却与1型菌株非常接近.挑选RAf11菌株和2型分支中的RAf19菌株,分别制备灭活苗,免疫雏鸭后进行攻菌保护试验,RAf11菌株对1型菌株的攻击可产生较高的交叉保护率,达53.8%,而RAf19菌株对1型菌株攻击的保护率仅为23.1%.借助16S rRNA和16S-23S rRNA间隔区序列的分析,筛选到一株具交叉保护的RA菌株.     

提前接种非致病尖孢镰刀菌防治西瓜枯萎病试验

将尖孢镰刀菌203株菌系接种在西瓜苗上,从中选出非致病尖孢镶刀菌系109个,分3个类群。用有促生作用,能在西瓜导管定殖的10个代表菌系提前接种,经温室和田间试验,结果表明316和317菌系的防病效果最好。在土壤含枯萎菌量2％条件下,推迟发病7～10天。在土壤含病菌量0.01％条件下,接种后25天,交叉保护防效分别为34.6％和68.2％。防病效果随枯萎菌量的下降而提高。     

鸡新城疫强度株的分离鉴定与免疫保护试验

从河北省保定地区发病鸡群中分离到2株有血凝性的分离物,其血凝作用可被NDV阳性血清所抑制,而不能被AIV(H9亚型)、EDS 76所抑制,表明2株分离物均为新城疫病毒。对2株NDV的毒力指数(MDT、IC-PI、IVPI)测定结果显示:MDT分别为40.8 h和53.7 h,ICPI分别为1.96和1.86,IVPI分别为2.89和2.72,表明2株NDV均为新城疫强毒株。采用分离的HBW株制成油乳剂灭活疫苗,分别以HBW株和LaSota株的灭活苗免疫试验鸡,进行疫苗免疫效果比较和交叉免疫保护试验。结果显示:(1)分离株灭活苗免疫组鸡各个时期所产生的HI抗体效价和Lasota灭活苗免疫组鸡的抗体效价相差不明显,2组的升降规律也基本一致。(2)分离株灭活苗免疫组鸡(HI抗体效价为6log2以上时)对相同剂量F48E9标准毒株和2个分离株的攻击可给予100%的保护,Lasota灭活苗免疫组鸡(HI抗体效价为6log2以上时)对相同剂量F48E9标准毒株和2个分离株的攻击不能给予100%的保护。说明NDV不同基因型毒株间的毒力和抗原性有一定的差异。     

鸡柔嫩艾美球虫DNA疫苗pcDNA4．0（C）-pEtK2-IL-2对其他球虫的交叉保护力

将柔嫩艾美球虫DNA疫苗pcDNA4．0（c）-pEtK2-IL-2以50μg分别对14日龄和21日龄雏鸡进行胸部肌肉注射免疫，28日龄对各未免疫组与免疫组鸡分别口服接种柔嫩艾美球虫、巨型艾美球虫、堆形艾美球虫和毒害艾美球虫孢子化卵囊，36日龄剖杀，分析比较免疫保护效果。结果显示，柔嫩艾美球虫攻毒免疫试验组与柔嫩艾美球虫攻毒未免疫对照组比较，增重、盲肠病变记分、OPG值差异显著（P〈0．05），免疫保护效果明显，抗球虫指数（ACI）达186．50；而巨型艾美球虫、堆形艾美球虫和毒害艾关球虫攻毒免疫试验组的ACI分别为147．85、142．71和153．82，增重、盲肠病变记分、OPG值和ACI与相应的攻毒未免疫对照组比较，均有不同程度改善，免疫保护效果不明显。表明，该DNA疫苗对柔嫩艾美球虫的攻击具有完全免疫保护作用，而对巨型艾美球虫、堆形艾关球虫、毒害艾美球虫的攻击具有部分交叉保护力。